Lam Research (NASDAQ:LRCX) Trading 1.9% Higher – Here’s What Happened

Lam Research Corporation (NASDAQ:LRCX)’s stock price was up 1.9% on Tuesday . The company traded as high as $166.36 and last traded at $165.81. Approximately 8,122,221 shares changed hands during trading, a decline of 31% from the average daily volume of 11,770,786 shares. The stock had previously closed at $162.74.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on LRCX shares. TD Cowen upped their target price on Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Citigroup upped their price objective on shares of Lam Research from $175.00 to $190.00 and gave the stock a “buy” rating in a research report on Tuesday, November 11th. HSBC set a $127.00 price target on shares of Lam Research and gave the company a “hold” rating in a research report on Tuesday, September 30th. Weiss Ratings reissued a “buy (b)” rating on shares of Lam Research in a research report on Monday. Finally, Hsbc Global Res raised shares of Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $152.87.

Lam Research Stock Up 1.9%

The company has a 50-day moving average of $150.65 and a two-hundred day moving average of $118.15. The company has a market capitalization of $208.26 billion, a P/E ratio of 36.52, a price-to-earnings-growth ratio of 1.63 and a beta of 1.77. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the prior year, the firm posted $0.86 earnings per share. The business’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a dividend yield of 0.6%. Lam Research’s dividend payout ratio (DPR) is 22.91%.

Insiders Place Their Bets

In related news, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction dated Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is currently owned by corporate insiders.

Institutional Trading of Lam Research

Large investors have recently modified their holdings of the company. IMG Wealth Management Inc. purchased a new stake in Lam Research during the second quarter worth $26,000. Stance Capital LLC purchased a new position in shares of Lam Research in the third quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research during the 2nd quarter worth about $27,000. Triumph Capital Management acquired a new stake in shares of Lam Research during the third quarter worth about $27,000. Finally, Strategic Wealth Investment Group LLC acquired a new stake in Lam Research during the 2nd quarter valued at approximately $29,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.